Rep. Julie Johnson Sells Procter & Gamble Company (The) (NYSE:PG) Shares

Representative Julie Johnson (D-Texas) recently sold shares of Procter & Gamble Company (The) (NYSE:PG). In a filing disclosed on December 11th, the Representative disclosed that they had sold between $1,001 and $15,000 in Procter & Gamble stock on November 13th. The trade occurred in the Representative’s “CHASE BROKERAGE ACCOUNT (3935)” account.

Representative Julie Johnson also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Charles Schwab (NYSE:SCHW) on 11/13/2025.
• Sold $1,001 – $15,000 in shares of UnitedHealth Group (NYSE:UNH) on 11/13/2025.
• Sold $1,001 – $15,000 in shares of Cigna Group (NYSE:CI) on 11/13/2025.
• Sold $1,001 – $15,000 in shares of Xcel Energy (NASDAQ:XEL) on 11/13/2025.
• Sold $1,001 – $15,000 in shares of Capital One Financial (NYSE:COF) on 11/13/2025.
• Sold $1,001 – $15,000 in shares of Walmart (NASDAQ:WMT) on 11/13/2025.
• Sold $1,001 – $15,000 in shares of Seagate Technology (NASDAQ:STX) on 11/13/2025.
• Sold $1,001 – $15,000 in shares of Wells Fargo & Company (NYSE:WFC) on 11/13/2025.
• Sold $1,001 – $15,000 in shares of Texas Instruments (NASDAQ:TXN) on 11/13/2025.
• Sold $1,001 – $15,000 in shares of The Goldman Sachs Group (NYSE:GS) on 11/13/2025.

Procter & Gamble Trading Up 1.4%

Shares of PG opened at $142.77 on Monday. The firm’s 50-day moving average is $147.84 and its two-hundred day moving average is $154.16. Procter & Gamble Company has a twelve month low of $138.14 and a twelve month high of $179.99. The company has a current ratio of 0.71, a quick ratio of 0.51 and a debt-to-equity ratio of 0.46. The firm has a market capitalization of $333.61 billion, a P/E ratio of 20.84, a PEG ratio of 4.80 and a beta of 0.39.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings results on Friday, October 24th. The company reported $1.99 EPS for the quarter, topping the consensus estimate of $1.90 by $0.09. Procter & Gamble had a return on equity of 32.63% and a net margin of 19.74%.The business had revenue of $22.39 billion for the quarter, compared to analyst estimates of $22.23 billion. During the same quarter in the previous year, the company earned $1.93 EPS. The company’s quarterly revenue was up 3.0% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. On average, research analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, November 17th. Shareholders of record on Friday, October 24th were given a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a yield of 3.0%. The ex-dividend date was Friday, October 24th. Procter & Gamble’s dividend payout ratio is presently 61.75%.

Wall Street Analysts Forecast Growth

PG has been the topic of several research reports. Barclays lowered their target price on Procter & Gamble from $153.00 to $151.00 and set an “equal weight” rating on the stock in a report on Monday, December 8th. Bank of America cut their target price on shares of Procter & Gamble from $180.00 to $174.00 and set a “buy” rating for the company in a research report on Wednesday, October 8th. Dbs Bank upgraded shares of Procter & Gamble to a “hold” rating in a research report on Friday, December 5th. Berenberg Bank raised their price objective on shares of Procter & Gamble from $152.00 to $154.00 and gave the stock a “hold” rating in a research note on Wednesday, September 17th. Finally, BNP Paribas Exane reduced their target price on Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating on the stock in a research note on Tuesday, September 23rd. Twelve research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $171.40.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of PG. MOKAN Wealth Management Inc. boosted its position in shares of Procter & Gamble by 13.7% in the 2nd quarter. MOKAN Wealth Management Inc. now owns 15,319 shares of the company’s stock valued at $2,442,000 after purchasing an additional 1,846 shares during the period. Westerkirk Capital Inc. purchased a new stake in Procter & Gamble during the second quarter valued at about $4,796,000. Vega Investment Solutions boosted its holdings in shares of Procter & Gamble by 1.3% in the second quarter. Vega Investment Solutions now owns 638,400 shares of the company’s stock worth $101,710,000 after buying an additional 8,500 shares during the period. Caliber Wealth Management LLC KS increased its position in shares of Procter & Gamble by 36.2% in the second quarter. Caliber Wealth Management LLC KS now owns 17,798 shares of the company’s stock worth $2,836,000 after acquiring an additional 4,730 shares in the last quarter. Finally, Jump Financial LLC purchased a new stake in shares of Procter & Gamble in the 2nd quarter valued at approximately $7,891,000. Institutional investors and hedge funds own 65.77% of the company’s stock.

Insider Activity

In other news, CEO Jon R. Moeller sold 11,684 shares of the stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $1,778,655.32. Following the completion of the sale, the chief executive officer owned 319,932 shares in the company, valued at $48,703,248.36. This represents a 3.52% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Jennifer L. Davis sold 3,227 shares of the firm’s stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $491,246.21. Following the completion of the sale, the chief executive officer directly owned 61,764 shares of the company’s stock, valued at approximately $9,402,333.72. This trade represents a 4.97% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 30,308 shares of company stock worth $4,611,852. 0.20% of the stock is owned by corporate insiders.

About Representative Johnson

Julie Johnson (Democratic Party) is a member of the U.S. House, representing Texas’ 32nd Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027.

Johnson (Democratic Party) ran for election to the U.S. House to represent Texas’ 32nd Congressional District. She won in the general election on November 5, 2024.

Julie Johnson earned a B.A. in history and government from the University of Texas at Austin in 1987 and a J.D. from the University of Houston Law Center in 1991. Johnson’s career experience includes working as an attorney.

Procter & Gamble Company Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.